EAST RUTHERFORD, N.J., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that fourth quarter and full year 2016 financial results will be released on Friday, February 3, 2017 before the market opens.
The Company will host a conference call to discuss the financial results.
|Fourth Quarter 2016 Earnings Conference Call|
|When:||Friday, February 3, 2017 at 8:30 a.m. Eastern Time|
|Dial-in:||1-888-726-2470 for U.S.|
|1-913-312-0696 for International|
|Dial-in Replay:||1-888-203-1112 for U.S.|
|1-719-457-0820 for International|
|Available through Friday, February 10, 2017|
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. For more information, please visit www.cambrex.com.
Contact: Stephanie LaFiura Investor Relations Associate Tel: 201-804-3037 Email: email@example.com